Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Wellbeing Digital Sciences Inc KONEF

Healthcare Psychedelics
Wellbeing Digital Sciences Inc. is an evidence-based mental healthcare company. The Company is focused on the development and implementation of clinical treatment solutions, including psychedelic medicine and digital therapeutics, as supported by clinical research. It operates through three segments: Wellbeing & IRP; KGK Science and Mindscape. It operates medical clinics across North America to help its patients access plant-based medicines, psychedelics, and other forms of mental health care, all of which have the potential to heal them of their physical and/or emotional pain. Its subsidiaries include Mindscape Ketamine & Infusions Therapy LLC, KGK Science Inc. and Integrated Rehab and Performance Ltd. It is supported by a network of North American clinics that provide therapies and other types of treatment to patients, as well as through a contract research organization that offers clinical trials services to clients pursuing drug development.


GREY:KONEF - Post by User

Wellbeing Digital Sciences Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(16)
•••
Post by waves1on Oct 18, 2021 4:39pm
88 Views
Post# 34019913

New $MEDI trials are an important milestone

New $MEDI trials are an important milestone
KetamineOne ($MEDI.ne $KONEF)'s recent announcement of two inaugural research studies for PTSD and depression patients is so important and a massive milestone for both $MEDI and society as a whole.
  1. Single-arm, open-label study of PTSD patients undergoing the proprietary physical therapy program at IRP clinics
  2. Observational, single-arm, pilot study to collect efficacy data in patients with depression receiving IV ketamine infusion therapy.
Given these trials have the potential to be breakthrough treatments for PTSD and depression patients, $MEDI is super undervalued right now and is a great investment into the medical ketamine and psychedelic industry IMO.
 

https://www.globenewswire.com/news-release/2021/10/14/2313950/0/en/Ketamine-One-Launching-Two-Inaugural-Research-Studies.html


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities